Delivery Order SPE2DB20D2104-SPE2DB24FT76Y
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $19K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,788.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product, with a completion date of May 1, 2024. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant...
- This federal contract award, valued at $37,273.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order contract for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, valued at $10,460.58, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a completion date of January 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There was no set-aside designation for this award. Amerisourcebergen Drug Corp holds significant Indefinite Delivery Contracts (IDCs)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,799.97 for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on April 5, 2022 with an ultimate completion date of April 6, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,915.46 for 4564299038 - DUPIXENT 200 MG/1.14 ML PEN 1.14ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on April 16, 2024, with a completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award, valued at $64,713.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order (SPE2DX15D1022|SPE2DX24FVHHE) for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, with a completion date of May 10, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award, valued at $14,104.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, with a completion date of January 4, 2024. The contract is a firm fixed-price arrangement and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier...
- This federal contract award, valued at $15,483.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals, a specialty medication used for medical treatment. The contract has an ultimate completion date of February 12, 2024 and is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $25,700.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a performance period that ends on July 14, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,171.07, is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 3, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...